Screening for macrocyclic peptides
Macrocyclic peptides are promising candidates for pharmaceuticals, but their screening is difficult. Scientists have now developed an easy-to-use, high-throughput screening assay for cyclic peptides with affinity to ubiquitin, a protein that helps to degrade proteins and induce cell death. The results could lead to novel drug candidates against cancer, according to the study published in the journal Angewandte Chemie.
Drugs based on peptides (small proteins) are often too large to pass through cell membranes. To make such peptides more compact and stable--and thus more efficient--researchers are investigating their closed versions, called macrocyclic ...















